Cytotoxic T-Lymphocyte responses elicited to wilms' tumor gene WT1 product by DNA vaccination

Journal of Clinical Immunology

Volumn 20, Issue 3, 2000, Pages 195-202

  Tsuboi, Akihiro ^a   Oka, Yoshihiro ^a   Ogawa, Hiroyasu ^a   Elisseeva, Olga A ^a   Li, Hanfen ^a   Kawasaki, Kotomi ^a   Aozasa, Katsuyuki ^a   Kishimoto, Tadamitsu ^b   Udaka, Keiko ^c   Sugiyama, Haruo ^a  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

^b OSAKA UNIVERSITY   (Japan)

^c KYOTO UNIVERSITY   (Japan)

Author keywords

CTL; DNA vaccine; Wilms' tumor gene; WT1

Indexed keywords

DNA VACCINE;

ANIMAL CELL; ARTICLE; CYTOTOXIC T LYMPHOCYTE; IMMUNE RESPONSE; MOUSE; NEPHROBLASTOMA; NONHUMAN; PRIORITY JOURNAL; TUMOR IMMUNOLOGY; VACCINATION;

ANIMALS; CYTOTOXICITY, IMMUNOLOGIC; DNA-BINDING PROTEINS; FEMALE; GENES, WILMS TUMOR; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; MICE; MICE, INBRED C57BL; PLASMIDS; T-LYMPHOCYTES, CYTOTOXIC; TRANSCRIPTION FACTORS; TUMOR CELLS, CULTURED; VACCINES, DNA; WT1 PROTEINS;

EID: 0033916081     PISSN: 02719142     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1006637529995     Document Type: Article

References (44)

1. Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms' tumor locus
2. Homozygous deletion in Wilms tumours of a zinc-finger gene identified by chromosome jumping
3. The Wilms' Tumor 1 gene: Oncogene or tumor suppressor gene?
4. Cytotoxic CD4+ and CD8+ T lymphocytes, generated by mutant p21-ras (12 Val) peptide vaccination of a patient, recognize 12 Val-dependent nested epitopes present within the vaccine peptide and kill autologous tumour cells carrying this mutation
5. Targeting p53 as a general tumor antigen
6. A nonapeptide encoded by human gene MAGE-1 is recognized on HLA-Al by cytolytic T lymphocytes directed against tumor antigen MZ2-E
7. Human gene MAGE-3 codes for an antigen recognized on a melanoma by autologous cytolytic T lymphocytes
8. Melanoma-specific CD4+ T cells recognize nonmutated HLA-DR-restricted tyrosinase epitopes
9. Identification of an immunodominant peptide of HER-2/neu protooncogene recognized by ovarian tumor-specific cytotoxic T lymphocyte lines
10. Human CTL epitopes encoded by human papilloma virus type 16 E6 and E7 identified through in vivo and in vitro immunogenicity studies of HLA-A*0201-binding peptides
11. Expression of the Wilms' tumor gene (WT1) in human leukemias
12. Expression of the candidate Wilms tumor gene, WT1, in human leukemia cells
13. WT1 as a new prognostic factor and a new marker for the detection of minimal residual disease in acute leukemia
14. The expression of the Wilms' tumor gene in acute myelocytic leukemias as a possible marker for leukemic blast cells
15. Presence of Wilms' tumor gene (WT1) transcripts and the WT1 nuclear protein in the majority of human acute leukemias
16. Aberrant overexpression of the Wilms' tumor gene (WT1) in human leukemia
17. Expression of the Wilms' tumor gene WT1 in solid tumors and its involvement in tumor cell growth
18. Growth inhibition of human leukemic Cells by WT1 (Wilms tumor gene) antisense oligonucleotides: Implications for the involvement of WT1 in leukemogenesis
19. Wilms' tumor gene (WT1) competes With differentiation-inducing signal in hematopoietic progenitor cells
20. Constitutive expression of the Wilms' tumor gene WT1 inhibits the differentiation of myeloid progenitor cells but promotes their proliferation in response to granulocyte-colony stimulating factor (G-CSF)
21. Human cytotoxic T lymphocyte responses Specific for peptides of wild-type Wilms' tumor gene WT1 product
22. Direct gene transfer into mouse muscle in vivo
23. Immunostimulatory DNA sequences necessary for effective intradermal gene immunization
24. Heterologous protection against influenza by injection of DNA encoding a viral protein
25. Cytokine enhancement of DNA immunization leads to effective treatment of established pulmonary metastases
26. Circumventing genetic restriction of protection against malaria with multigene DNA immunization: CD8+ cell-, interferon gamma-, and nitricoxide-dependent immunity
27. DNA vaccines
28. Isolation, characterization, and expression of the murine Wilms' tumor gene (WT1) during kidney development
29. The Wilms tumor gene WT1 is expressed in murine mesoderm-derived tissues and mutated in a human mesothelioma
30. Multiple roles for the Wilms' tumor suppressor, WT1
31. Tumor antigens
32. T cell defined tumor antigen
33. Cytotoxic T cell response against chimeric p210 BCR-ABL protein in patients with chronic myelogenous leukemia
34. Cytotoxic T cell response against the chimeric ETV6-AML1 childhood acute lymphoblastic leukemia
35. T cell recognize the V(H) complementarity-determining region 3 of the idiotypic protein of B cell non-Hodgkin's lymphoma
36. DNA vaccines
37. DNA vaccine strategies for the treatment of cancer
38. Gene vaccination with naked plasmid DNA: Mechanism of CTL priming
39. Immune response to a carcinoembryonic antigen polynucleotide vaccine
40. Helper activity is required for the in vivo generation of cytotoxic T lymphocytes
41. Three-cell-type clusters of T cells with antigen-presenting cells best explain the epitope linkage and noncognate requirements of the in vivo cytolytic response
42. + T cell help
43. Cytotoxic T cell responses to DNA vaccination: Dependence on antigen presentation via class II MHC
44. Cancer immunotherapy targeting Wilms' tumor gene WT1 product